A carregar...
Azilsartan/chlorthalidone combination therapy for blood pressure control
BACKGROUND: Edarbyclor(®) is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011 by the US Food and Drug Administration (FDA) for hypertension management. OBJECTIVE: To review the pharmacology, pharmacokineti...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3685454/ https://ncbi.nlm.nih.gov/pubmed/23807859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IBPC.S34792 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|